TGFB1 and diabetes mellitus: In vivo data proved that TgN-Sestrin2 mice with STZ-induced diabetes were protected from renal lesions, podocyte loss, podocyte phenotypic alterations, increased expression of apoptosis-associated proteins, oxidative stress, and TSP-1/TGF-β1/Smad3 activation.